David Michael Williams, Executive Vice President and Chief Information & Digital Officer at Merck (NSE:PROR) & Co., Inc.

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...

Merck & Co has said building its cardiovascular medicines business is central to its strategy to manage the loss of patent protection of cancer juggernaut Keytruda in five years, and new studies ...

The Institute of Chemical Technology, Mumbai, in collaboration with the Mumbai Biocluster, successfully hosted the 5th Annual ...

Robert F Kennedy Jr was confirmed as US Secretary of Health and Human Services in a 52-48 Senate vote. The vaccine skeptic will oversee agencies like the FDA, CDC, and NIH. His ‘Make America Healthy ...

Opdualag – which combines the PD-1 inhibitor nivolumab in BMS' blockbuster cancer drug Opdivo with LAG-3 inhibitor relatlimab ...

Robert F Kennedy Jr has been approved by the Senate and sworn in by President Donald Trump as head of the US Department of Health and Human Services.12 After being sworn in on 13 February, Kennedy, ...